In Indiana last year, dozens of insurers across the state rolled out plans hoping to get a sizable piece of the fast-growing market.
Catching COVID on a business trip can get complicated
Not only do you have to rearrange plans to visit customers or attend conferences, but you suddenly need to isolate in a hotel room, find restaurants that deliver, and perhaps reschedule flight and hotel plans.Read More
Crowded ERs divert ambulances in huge numbers, state data shows
Central Indiana hospitals diverted ambulances for nearly 3,000 hours during a six-week period this fall, according to information IBJ received from the Indiana State Department of Health through an open-records request.Read More
Legislation pits religious freedoms against employer rights
For the past year, Indiana employers have faced the challenge of whether to enforce COVID-19 vaccination mandates on workers who say the vaccines violate their religious beliefs.Read More
Indiana University Health, the state’s largest hospital system, recently hired 700 traveling nurses to work in its 16 hospitals under 13-week contracts.
Fast-growing software company Greenlight Guru recently moved into new, bigger office space at the Union Campus on South Meridian Street. The company says it is committed to maintaining physical offices, even as its remote workforce grows.
People needing a COVID-19 test for travel, work or school are spending hours, sometimes days, looking for a place that can squeeze them in and turn around results quickly.
According to a report by the Indiana Economic Development Corp., the Hoosier state ranks second nationally for worldwide life sciences exports and among the top five states for life sciences industry jobs.
The sectors in central Indiana account for one out of every 10 jobs here, or 164,144 workers, and the jobs pay an average of $77,229, according to the report commissioned by BioCrossroads.
Indianapolis’ newest publicly company, Point Biopharma Inc., is the latest player in a field expected to see explosive growth as doctors and researchers look for new ways to shrink tumors.
Gil Peri, a 6-foot, 8-1/2-inch, gregarious administrator with an easy laugh, started his job on June 28, after spending about four years as president and chief operating officer at Connecticut Children’s Medical Center.
The agreement from multiple state attorneys general, including those who had most aggressively opposed Purdue’s original settlement proposal, was disclosed late Wednesday.
Indiana University Health has created a lab to testing the vulnerability of hundreds or even thousands of devices, to protect both patients and the hospital system’s records.
Mathilde Merlet oversees one of Eli Lilly and Co.’s fastest-growing products, a medicine called Taltz that treats a variety of dermatology and rheumatology disorders.
The announcement comes five months after the company introduced its new product Halo, which uses artificial intelligence to make recommendations related to the quality of medical devices.
With the help of a $2.3 million grant, Purdue University animal science professor Shihuan Kuang’s research will continue in an effort to better understand the origin and function of these newly-discovered stem cells.
The Novavax vaccine, which is easy to store and transport, is expected to play an important role in boosting vaccine supplies in the developing world.
Neuro Vigor says it will use $100,000 in early commercialization funds to “identify and validate” its lead drug candidate for the treatment of neuropathic pain in spinal cord injuries.
Emerging from the pandemic, health and life sciences companies have a unique opportunity to leverage lessons learned for the benefit of the patients they serve.
Matthew Sause took the helm of the 4,500-person Roche Diagnostics’ North American operations in Indianapolis in November 2019—just four months before the World Health Organization declared a pandemic and much of the planet went into lockdown.
This is a partial transcript of IBJ’s annual Life Sciences Power Panel, which took place virtually on April 30 with four of Indy’s biosciences leaders: 16 Tech CEO Bob Coy, GenePace Laboratories founder Sanjay Malkani, Elanco Animal Health CEO Jeff Simmons and Indiana University School of Medicine geneticist Tatiana Foroud.